Main Article Content
Clinically, antimicrobial susceptibility testing results provide guidance in the choice of antimicrobial agents in patient care. The accuracy of results from antimicrobial susceptibility testing can be affected by multiple factors including the media, antimicrobial discs or preparations, inoculum’s size, plate reading and incubation conditions. Misleading results from antimicrobial susceptibility test leads to the indiscriminate and irrational use of antibiotics and have impacted grossly to the global challenge of antimicrobial resistance. The objectives of this study were to compare the efficacy of different brands of locally and foreign manufactured multi-antibiotic discs on bacteria and assess any significant variation. Two brands each of locally and foreign manufactured multi-antibiotic discs were purchased from retail stores within the FCT. The antibacterial susceptibility of Staphylococcus aureus ATCC 25923, Salmonella typhi ATCC 9150, Klebsiella pneumonia, Pseudomonas aeruginosa, Bacillus subtilis, Escherichia coli ATCC 25922 and Streptococcus pyogenes were carried out using agar diffusion method. There were differences between the diameter zones of inhibition produced by the local brands and the foreign brands of antibiotic discs. Amoxicillin/clavulanic acid (30 µg) disc produced the highest variation within the four brands with zones of inhibition range 12.0 – 20.0 mm against the test organisms. There is need for regulatory bodies like NAFDAC and SON to routinely validate and assess the qualities of these products in the market.
Tenover FC, Mohammed JM, Stelling JO, Brien T, Williams R. Ability of laboratories to detect emerging antimicrobial resistance: Proficiency testing and quality control results from the World Health Organisation’s external quality assurance system for antimicrobial susceptibility testing. J. Clin. Microbiol. 2001;39(1):241-250.
King A, Brown DF. Quality assurance of antimicrobial susceptibility testing by disc diffusion. J. Antimicr. Chemother. 2001; 48:S1: 71-76.
Silva E, Díaz JA, Arias MJ, Hernández, AP, Torre A. BMC Clinical Pharmacology. 2010;10:3.
Chanda W, Manyepa M, Chikwanda E, Daka V, Chileshe J, Tembo M, et al. Evaluation of antibiotic susceptibility patterns of pathogens isolated from routine laboratory specimens at Ndola Teaching Hospital: A retrospective study. PLoS ONE 2019;14(12):1-14.e0226676. Available:https://doi.org/10.1371/journal.pone.0226676
Anyadoh-Nwadike SO, Okorondu SI, Obiajuru IOC, Nwadike PO, Nwaokorie FO, Akerele JO. Comparative study of the prevalence and antibiogram of bacterial isolates from the urinary and genital tracts of antenatal patients. 2015;10(1):5–9.
Eze PM, Ajaegbu EE, Ejikeugwu PC, Egbuna PR, Abba CC, Esimone CO. Evaluation of the quality of commercial antibacterial discs available in Nigeria. British Journal of Pharmaceutical Research. 2014;4(21):2548-2562.
Andrews J.M. BSAC standardized disc susceptibility testing method. Antimicr. Chemother. 2003;48:43-57.
Sudha V, Prasad A, Khare S, Bhatia R. Antimicrobial susceptibility testing in India – A status survey. Indian J. Med. Microbiol. 2001;19:222-223.
Khan ZA, Siddiqui MF, Park S. Current and emerging methods of antibiotic susceptibility testing. Diagnostics. 2019; 49(9):1-17.
Nassar MSM, Hazzah WA, Bakr WMK. Evaluation of antibiotic susceptibility test results: How guilty a laboratory could be? Journal of the Egy. Public Health Asso. 2019;94(4):1-5.
Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial disc susceptibility tests. CLSI (M100). 27th Edition. 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA; 2017.
Zadbuke N, Shahi S, Gulecha B, Padalkar A, Thube M. Recent trends and future of pharmaceutical packaging technology. J Pharm Bioall Sci. 2013;5:98-110.